The COVID-19 pandemic was caused by the recently emerged β-coronavirus SARS-CoV-2. SARS-CoV-2 has had a catastrophic impact, resulting in nearly 7 million fatalities worldwide …
S ŞİMŞEK YAVUZ… - Turkish journal of …, 2021 - search.ebscohost.com
Background/aim: Currently there is not an effective antiviral treatment for COVID-19, but a large number of drugs have been evaluated since the beginning of the pandemic, and many …
Although significant research has been done to find effective drugs against coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 …
SE Nystrom, G Li, S Datta, KL Soldano, D Silas… - JCI insight, 2022 - ncbi.nlm.nih.gov
COVID-19 infection causes collapse of glomerular capillaries and loss of podocytes, culminating in a severe kidney disease called COVID-19–associated nephropathy …
Simple Summary Treatments for coronavirus disease-2019 (COVID-19) have utilized a variety of medications, including antivirals, immunomodulators, and other therapeutics such …
G Bellucci, A Albanese, C Rizzi, V Rinaldi… - Frontiers in …, 2023 - frontiersin.org
Interferon-beta (IFN-β) for Multiple Sclerosis (MS) is turning 30. The COVID-19 pandemic rejuvenated the interest in interferon biology in health and disease, opening translational …
Background The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive …
A Nakhlband, A Fakhari, H Azizi - Journal of medical virology, 2021 - Wiley Online Library
The newborn coronaivus disease 2019 (COVID‐19) pandemic has become the foremost concern of health system worldwide. Interferon typeI (IFN‐I) are among the well‐known …
H Tamir, S Melamed, N Erez, B Politi… - Viruses, 2022 - mdpi.com
SARS-CoV-2, a member of the coronavirus family, is the causative agent of the COVID-19 pandemic. Currently, there is still an urgent need in developing an efficient therapeutic …